Patents by Inventor Ponnampalli Swapna

Ponnampalli Swapna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of new benzothiazole derivatives as potential anti-tubercular agents
    Patent number: 9949970
    Abstract: Disclosed are compounds of general formula A useful as potential anti-tubercular agents.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: April 24, 2018
    Assignee: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    Inventors: Ahmed Kamal, Rajesh Vcrnc Shetti, Ponnampalli Swapna, Shaik Azeeza, A. Malla Reddy, Inshad Ali Khan, Sheikh Tasduq Abdullah, Sandeep Sharma, Nitin Pal Kalia
  • SYNTHESIS OF NEW BENZOTHIAZOLE DERIVATIVES AS POTENTIAL ANTI-TUBERCULAR AGENTS
    Publication number: 20160175303
    Abstract: Disclosed are compounds of general formula A useful as potential anti-tubercular agents.
    Type: Application
    Filed: March 1, 2016
    Publication date: June 23, 2016
    Inventors: Ahmed KAMAL, Rajesh VCRNC SHETTI, Ponnampalli SWAPNA, Shaik AZEEZA, A. Malla REDDY, Inshad Ali KHAN, Sheikh Tasduq ABDULLAH, Sandeep SHARMA, Nitin Pal KALIA
  • Synthesis of new benzothiazole derivatives as potential anti-tubercular agents
    Patent number: 9273039
    Abstract: The present disclosure provides compounds of general formula A: useful as potential anti-tubercular agents.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: March 1, 2016
    Assignee: Council of Scientific and Industrial Research
    Inventors: Ahmed Kamal, Rajesh Vcrnc Shetti, Ponnampalli Swapna, Shaik Azeeza, A Malla Reddy, Inshad Ali Khan, Sheikh Tasduq Abdullah, Sandeep Sharma, Nitin Pal Kalia
  • 3-arylethynyl substituted quinazolinone compounds
    Patent number: 8680272
    Abstract: The present invention provides 3-arylethynyl substituted quinazolinone compounds of formula (A) as potential anticancer agents against sixty human cancer cell lines. R1?H, OH, OCH3; R2?H, OH, CH3, OCH3, NO2; R3?H, OH, OCH3, F, Cl; R2+R3=—OCH2O—; R4?H, OH, CH3, OCH3; R5?H, OH, CH3, OCH3; R6?H, OCH3.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: March 25, 2014
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Farheen Sultana, Erla Vijaya Bharathi, Yellamelli Valli Venkata Srikanth, Arutla Viswanath, Ponnampalli Swapna
  • 3-ARYLETHYNYL SUBSTITUTED QUINAZOLINONE COMPOUNDS
    Publication number: 20130317221
    Abstract: The present invention provides 3-arylethynyl substituted quinazolinone compounds of formula (A) as potential anticancer agents against sixty human cancer cell lines. R1=H, OH, OCH3; R2=H, OH, CH3,OCH3, NO2; R3=H, OH, OCH3, F, Cl; R2+R3=—OCH2O—; R4=H, OH, CH3, OCH3; R5=H, OH, CH3, OCH3; R6=H, OCH3.
    Type: Application
    Filed: March 31, 2011
    Publication date: November 28, 2013
    Applicant: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Farheen Sultana, Erla Vijaya Bharathi, Yellamelli Valli Venkata Srikanth, Arutla Viswanath, Ponnampalli Swapna